Farther Finance Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $266K | Buy |
6,923
+838
| +14% | +$32.2K | 0.01% | 1241 |
|
|
2025
Q1 | $230K | Buy |
6,085
+2,030
| +50% | +$76.9K | 0.01% | 1171 |
|
|
2024
Q4 | $137K | Sell |
4,055
-1,530
| -27% | -$51.7K | 0.01% | 1170 |
|
|
2024
Q3 | $228K | Sell |
5,585
-472
| -8% | -$19.3K | 0.01% | 941 |
|
|
2024
Q2 | $232K | Buy |
6,057
+2,081
| +52% | +$79.9K | 0.01% | 780 |
|
|
2024
Q1 | $169K | Buy |
3,976
+123
| +3% | +$5.22K | 0.01% | 744 |
|
|
2023
Q4 | $143K | Buy |
3,853
+2,037
| +112% | +$75.5K | 0.01% | 674 |
|
|
2023
Q3 | $65.8K | Buy |
1,816
+461
| +34% | +$16.7K | 0.01% | 691 |
|
|
2023
Q2 | $48.3K | Sell |
1,355
-30
| -2% | -$1.07K | 0.01% | 684 |
|
|
2023
Q1 | $49.3K | Buy |
1,385
+1,050
| +313% | +$37.4K | 0.01% | 603 |
|
|
2022
Q4 | $11.8K | Buy |
+335
| New | +$11.8K | ﹤0.01% | 893 |
|